Brazil Develops Low-Cost Surgical Technique to Expand Prostate Cancer Care
Researchers at the State University of Rio de Janeiro (Uerj) have developed an innovative surgical method that replicates the logic of robotic surgery using conventional instruments. This breakthrough aims to make high-precision prostate cancer treatment more accessible within Brazil’s Unified Health System (SUS) by eliminating the prohibitive costs typically associated with robotic platforms.
Prostate cancer is currently the most frequent malignancy among men in Brazil, excluding non-melanoma skin cancers. Given this prevalence, the development of surgical techniques that are simultaneously effective, safe, and affordable has become a strategic priority for both public and private healthcare systems. Expanding access to such high-precision techniques is critical for reducing health disparities and ensuring that life-saving surgical innovations reach underserved populations.
The evolution of the radical prostatectomy—a surgery designed to completely remove the prostate with curative intent—has been driven by significant technological leaps and a deeper understanding of anatomy. In the 1980s, urologist Patrick Walsh revolutionized the field by demonstrating that it was possible to preserve the nerve bundles responsible for erections, a move that significantly reduced post-operative complications and improved patients’ quality of life.
The 1990s introduced laparoscopy, which allowed for smaller incisions and faster recovery times. However, this method faced limited adoption due to its high technical complexity and a steep learning curve that only a small number of surgeons were able to master.
The landscape shifted again in the 2000s with the introduction of robotic surgery, specifically the da Vinci system. This technology provided surgeons with three-dimensional vision and enhanced precision in movement, simplifying the execution of laparoscopic prostatectomies. Despite these advantages, the expansion of robotic surgery in middle-income countries like Brazil has been hindered by extreme costs related to equipment acquisition, maintenance, and disposable instruments.
Whereas robotic surgery is noted for accelerating patient recovery, scientific studies indicate that its oncological and functional results are equivalent to those achieved through traditional open surgery. The new method developed by Uerj researchers seeks to bridge this gap, offering the precision logic of robotics without adding financial burdens to the healthcare system.
This advancement aligns with a broader trend of robotic surgery advancing in Brazil, where technology is being used to increase precision, reduce complications, and speed up patient recovery. By mimicking these high-tech results through conventional means, the Uerj innovation provides a pathway for more patients to regain their quality of life after beating cancer.
